Anavex Life Sciences Corp
anavex.comWhat Do They Do?
Develops potential treatments for central nervous system diseases, including Alzheimer’s, Parkinson’s and rare neurodevelopmental disorders, using genetic data from clinical trials to identify biomarkers.
10-K for FY2025, filed Nov 25, 2025
Sources
How Do They Make Money?
No revenue reported yet.
10-K for FY2025, filed Nov 25, 2025
Sources
How Are They Changing?
Since the FY2025 annual report
Latest quarter: Q3 FY2026, the three months to Jun 30, 2026
- Net income
-
Sources
10-Q for Q3 FY2026, filed Aug 28, 2026
$7.8MView ↗
- ▲ Now profitable
- vs −$13.2M in Q3 FY2025
-
Aug 3, 2026
Anavex terminated its CEO and appointed an interim CEO
The board said Terrie Kellmeyer was appointed interim CEO after Christopher Missling’s termination.
Sources
8-K, filed Aug 3, 2026
Mr. Patel and Dr. Senderowicz, along with independent chairperson Dr. Jiong Ma, and independent directors Dr. Peter Donhauser, Dr. Axel…View ↗
Loading...
Comments
